Status:
COMPLETED
Nutritional Intervention and DNA Damage of Patients With HBOC
Lead Sponsor:
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Conditions:
HBOC Syndrome
DNA Damage
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Breast and Ovarian Cancer Syndrome (HBOC) is characterized by mutations in tumor suppressor genes such as BRCA1 and BRCA2, which increase the carrier's risk of developing breast and ovarian cancer, es...
Detailed Description
Breast and Ovarian Cancer Syndrome (HBOC) is a genetic disease characterized by mutations in tumor suppressor genes such as BRCA1 and BRCA2, elevation of Reactive Oxygen Species (ROS), inflammation an...
Eligibility Criteria
Inclusion
- Female patients diagnosed with HBOC according to the Mexican Consensus of Breast Cancer
- Patients over 18 years who voluntarily agree to participate in the study and sign the informed consent.
Exclusion
- Patients with end-stage chronic kidney failure, heart failure, liver failure, rheumatoid arthritis, non-inherited AC or HIV.
- Patients who carry out a structured exercise plan (rehabilitation) at the time of inclusion in the study.
- Patients who carry out a structured eating plan (adherence to diet) or who are consuming a food supplement at the time of inclusion in the study.
- Patients with significant primary clinical disorders: hematological (hemoglobin \<13 in men and \<12 in women), renal (creatinine\> 3), neurological (other than epilepsy).
Key Trial Info
Start Date :
November 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05306002
Start Date
November 28 2017
End Date
December 31 2022
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
María Fernanda Díaz Yáñez
Mexico City, Benito Juárez, Mexico, 03420